^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CD44 expression

    i
    Other names: CD44, CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
    Entrez ID:
    960
    Related biomarkers:
    Expression
    Apply
    Dissecting the Biology of Early-onset Colorectal Cancer (NCT05916443)
    Phase N/A
    Fondazione Policlinico Universitario Agostino G...
    Not yet recruiting
    Last update posted :
    07/24/2023
    Initiation :
    08/01/2023
    Primary completion :
    06/30/2024
    Completion :
    09/30/2025
    CD44 • CD24
    |
    CD33 positive • CD44 expression • CD133 positive
    18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules (NCT02448225)
    Phase 2
    Vanderbilt-Ingram Cancer Center
    Completed
    Last update posted :
    10/19/2022
    Initiation :
    06/16/2015
    Primary completion :
    08/02/2021
    Completion :
    10/10/2022
    CD44
    |
    CD44 expression
    Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer (ONAWA) (NCT04142892)
    Phase 1
    SOLTI Breast Cancer Research Group
    Completed
    Last update posted :
    04/01/2022
    Initiation :
    11/06/2020
    Primary completion :
    04/30/2021
    Completion :
    04/30/2021
    HER-2 • ER • CD24 • ALDH1A1
    |
    ER positive • HER-2 negative • CD44 expression • PGR expression
    |
    Apristor (onapristone XR)
    Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT (NCT04137653)
    Phase 3
    Shengjing Hospital
    Recruiting
    Last update posted :
    07/20/2021
    Initiation :
    07/19/2021
    Primary completion :
    11/30/2025
    Completion :
    11/30/2026
    ER • PGR • CD44 • CD24
    |
    CD44 expression
    |
    carboplatin • albumin-bound paclitaxel
    Multi-4SCAR-T Therapy Targeting Breast Cancer (NCT04430595)
    Phase 1/2
    Shenzhen Geno-Immune Medical Institute
    Recruiting
    Last update posted :
    06/12/2020
    Initiation :
    06/01/2020
    Primary completion :
    05/31/2023
    Completion :
    12/31/2023
    HER-2
    |
    HER-2 expression • CD44 expression
    |
    4SCAR-T
    Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma (NCT04137627)
    Phase 3
    Indonesia University
    Completed
    Last update posted :
    12/09/2019
    Initiation :
    07/04/2017
    Primary completion :
    07/30/2018
    Completion :
    12/18/2018
    HIF1A • CD44
    |
    CD44 expression • CD133 expression • HIF1A expression
    |
    cisplatin
    Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer (NCT01688609)
    Phase 2
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    09/11/2017
    Initiation :
    07/01/2012
    Primary completion :
    12/01/2013
    Completion :
    08/15/2016
    EGFR • HER-2 • ALDH1A1
    |
    EGFR mutation • HER-2 overexpression • HER-2 amplification • CD44 expression
    |
    Herceptin (trastuzumab) • paclitaxel • lapatinib
    A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors (NCT01358903)
    Phase 1
    Hoffmann-La Roche
    Completed
    Last update posted :
    11/02/2016
    Initiation :
    06/01/2011
    Primary completion :
    03/01/2014
    Completion :
    03/01/2014
    CD44
    |
    CD44 expression